DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Cenicriviroc is an investigational drug.
There have been 16 clinical trials for Cenicriviroc. The most recent clinical trial was a Phase 2 trial, which was initiated on April 20th 2017.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Cirrhosis. The leading clinical trial sponsors are Tobira Therapeutics, Inc., Allergan, and University of California, San Francisco.
There are two hundred and sixty-three US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Cenicriviroc
|Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV||Allergan, plc||Phase 2|
|Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 2|
|Immune Modulators for Treating COVID-19||Biomedical Advanced Research and Development Authority||Phase 2|
Top disease conditions for Cenicriviroc
Top clinical trial sponsors for Cenicriviroc
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Cenicriviroc||Get Started Free||Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections||EMORY UNIVERSITY (Atlanta, GA)||Get Started Free|
|Cenicriviroc||Get Started Free||Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus||YALE UNIVERSITY (New Haven, CT)||Get Started Free|
|Cenicriviroc||Get Started Free||Inhibitors of human immunodeficiency virus replication||ViiV HEALTHCARE UK (NO. 5) LIMITED (Brentford, Middlesex, GB)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Cenicriviroc||Australia||AU2012345732||2031-11-30||Get Started Free|
|Cenicriviroc||Australia||AU2016244212||2031-11-30||Get Started Free|
|Cenicriviroc||Brazil||BR112014013224||2031-11-30||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|